Return to Article Details
EVALUATION OF RESULTS OF FIRST-LINE AFATINIB TREATMENT IN STAGE IV EGFR-MUTATION NON-SMALL CELL LUNG CANCER PATIENTS AT NGHE AN ONCOLOGY HOSPITAL
Download
Download PDF